A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs

LORENZUTTI AUGUSTO MATÍAS; HIMELFARB MARTÍN ALEJANDRO; MARTÍN-FLORES MANUEL; INVALDI SERGIO HERNÁN; LITTERIO NICOLÁS JAVIER; ZARAZAGA MARÍA DEL PILAR

CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE

CANADIAN VET MED ASSOC

Año: 2017 vol. 58 p. 35 - 38

0008-5286

Morphine is widely used as a preanesthetic agent in dogs, but it often produces signs of nausea and vomiting. Maropitant (MRP) and metoclopramide (MCP) prevent emesis attributable to the opioid agent apomorphine in dogs. We evaluated the antiemetic efficacy and the discomfort in response to SQ injection of MRP [1 mg/kg body weight (BW)], MCP (0.5 mg/kg BW), and normal saline (SAL; 0.1 mL/kg BW) administered to 63 dogs, 45 minutes prior to morphine (0.5 mg/kg BW) and acepromazine (0.05 mg/kg BW). Dogs were observed for signs of nausea (ptyalism, lip licking, and increased swallowing) and vomiting for 30 minutes after morphine/acepromazine. The incidence of emesis was 0% for MRP, 38% for MCP, and 71% for SAL (P < 0.001). The incidence of signs of nausea was not different between groups. Discomfort due to injection was higher after MRP (48%), than after MCP (9.8%) and SAL (4.8%) (P < 0.001).